Latest Articles
Depo Provera Lawsuit Settlement | Sept 2025 Litigation Update - Lawsuit Information Center
Depo Provera Lawsuit Settlement | Sept 2025 Litigation Update Lawsuit Information Center
Published: Sept. 26, 2025, 5:53 p.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com Australia
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com Australia
Published: Sept. 26, 2025, 11:03 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com South Africa
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com South Africa
Published: Sept. 26, 2025, 10:56 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com India
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com India
Published: Sept. 26, 2025, 10:48 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com
Published: Sept. 26, 2025, 10:25 a.m.
Hormonal milieu influences whole-brain structural dynamics across the menstrual cycle using dense sampling in multiple individuals - Nature
Hormonal milieu influences whole-brain structural dynamics across the menstrual cycle using dense sampling in multiple individuals Nature
Published: Sept. 26, 2025, 10:18 a.m.
Why Denison Mines Corp Ordinary Shares stock remains top rated - Portfolio Performance Summary & Real-Time Sentiment Analysis - newser.com
Why Denison Mines Corp Ordinary Shares stock remains top rated - Portfolio Performance Summary & Real-Time Sentiment Analysis newser.com
Published: Sept. 26, 2025, 10:05 a.m.
When women need permission to heal, everyone pays - Dawn
When women need permission to heal, everyone pays Dawn
Published: Sept. 26, 2025, 7:07 a.m.
Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Non-Hormonal Endometriosis Therapy.
Previous studies show that orphan nuclear receptor 4A1 (NR4A1) regulated endometriotic cell growth, survival, estrogen receptor β (ERβ), mTOR signaling and fibrosis. NR4A2 is also expressed in epithelial and stromal …
Published: Sept. 26, 2025, midnight
Endometriosis Diagnostic Delay and Its Correlates: Results from the ComPaRe-Endometriosis Cohort.
Background: An average time to diagnosis of 7 years is commonly described for endometriosis; diagnostic delay for adenomyosis is unknown. This cross-sectional study aimed to describe diagnostic delay for endometriosis …
Published: Sept. 26, 2025, midnight
Link copied to clipboard!